Clinical Trials Logo

Clinical Trial Summary

The goal of this randomized clinical trial is to compare the adjunctive use of enamel matrix derivatives in the treatment of tooth autotransplantation in terms of clinical attachment level. The main question it aims to answer. What is the benefit, in terms of clinical attachment level and probing depths, of using enamel matrix derivatives adjunctive to tooth autotransplantation? Participants will be subjected to a digitally guided surgery of tooth autotransplantation. The protocol of the test group will be supplemented with the application of enamel matrix derivatives before the placement of the transplanted tooth into the surgically produced alveolus.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06250088
Study type Interventional
Source Universidad Complutense de Madrid
Contact
Status Recruiting
Phase Phase 4
Start date March 12, 2024
Completion date March 1, 2026

See also
  Status Clinical Trial Phase
Completed NCT01149863 - Alteration in Timing of Plerixafor Administration Phase 2
Completed NCT00741780 - Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662). N/A
Completed NCT00741325 - Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610). N/A
Completed NCT00955669 - Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer Phase 1